British pharmaceutical giant AstraZeneca on Monday said an interim analysis of clinical trials showed its coronavirus vaccine has an average efficacy of 70% in protecting against the virus.
from Health and Science https://ift.tt/2UT8KuQ
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH
No comments:
Post a Comment